
Vitavog 0.3 Tablet DT
Marketer
Vitabolik Pharma
Salt Composition
Voglibose (0.3mg)
Overview Vitavog 0.3 Tablet DT
Diabetol 0.3mg Tablet is prescribed for managing type 2 diabetes. It helps regulate postprandial hyperglycemia (elevated blood sugar after meals). This medication is indicated when dietary modifications and other antidiabetic agents prove insufficient to control blood glucose. Diabetol 0.3mg Tablet should be administered immediately prior to meals. Dosage and frequency are determined by your physician to optimize glycemic control. Discontinuing this medication abruptly without medical supervision is strongly discouraged; abrupt cessation may lead to dangerously elevated blood sugar and potentially serious complications, such as nephropathy and visual impairment. Successful treatment requires adherence to a comprehensive plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential. Commonly reported adverse effects include intestinal gas, abdominal discomfort, anorexia, constipation, and diarrhea. Report any persistent or bothersome side effects to your doctor. While Diabetol 0.3mg Tablet itself doesn't induce hypoglycemia, concomitant use with other diabetes medications (particularly insulin or sulfonylureas) may increase this risk. If hypoglycemia occurs, treat with plain glucose; sucrose or other common sugars may be ineffective. Inform your physician of any pre-existing renal or hepatic dysfunction before commencing treatment. This medication is contraindicated in individuals with bowel inflammation or ulceration (e.g., Crohn's disease, ulcerative colitis). Pregnant or lactating individuals should seek medical advice prior to use. Always disclose all medications to your doctor to ensure treatment safety. Limit alcohol consumption while taking Diabetol 0.3mg Tablet to minimize the hypoglycemic risk.
Uses of Vitavog 0.3 Tablet DT
Managing type 2 diabetes
Major Benefits of Vitavog 0.3 Tablet DT:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Dissolve one tablet in water before consumption. Administer Vitavog 0.3 DT Tablet on an empty stomach.
Common Side effects of Vitavog 0.3 Tablet DT:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Vitavog 0.3 Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Dissolve the Vitavog 0.3 DT tablet in water before consumption. Administer on an empty stomach.
How Vitavog 0.3 Tablet DT works:
Diabetol 0.3mg delayed-release tablets are an anti-hyperglycemic medication. Their mechanism involves suppressing intestinal enzymes that digest complex carbohydrates into readily absorbable glucose, thus moderating postprandial hyperglycemia.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vitavog 0.3 Tablet DT and alcohol is contraindicated.
PregnancySAFE IF PRESCRIBED
Pregnant women can typically use Vitavog 0.3 DT tablets safely. Animal research indicates minimal or no negative consequences for the fetus; however, human data is scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Vitavog 0.3 DT tablets safely. Available human data indicates minimal infant risk associated with the medication.
DrivingSAFE
Driving ability is typically unaffected by Vitavog 0.3 DT tablets.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Vitavog 0.3 Tablet DT. Dosage modification of Vitavog 0.3 Tablet DT might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Vitavog 0.3 Tablet DT cautiously, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Vitavog 0.3 Tablet DT :
Omit any missed Vitavog 0.3 Tablet DT and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vitavog 0.3 Tablet DT
| Label | Value |
|---|---|
| Chemical Category | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Behavioral Class | Alpha-glucosidase inhibitors |
